European Association of Dermato-Oncology 11th World Congress of Melanoma and 21st EADO Congress 2025

• Target Audience: dermatologists, oncologists, surgeons, and pathologists specializing in skin cancer
• Sample video: contact me for sample video
• Information:

The 11th World Congress of Melanoma combined with the 21st EADO Congress 2025 is a premier international event uniting specialists from around the globe to advance knowledge and practice in dermato-oncology. This congress offers a rich scientific program with plenary sessions, interactive symposia, workshops, and case-based learning covering every aspect of melanoma and skin cancer management.

What You Will Learn

Latest advances in prevention, diagnosis, staging, and treatment of melanoma and other skin cancers

Innovative surgical and non-surgical therapies, including immunotherapy and targeted treatments

Case-based discussions focusing on complex and rare cutaneous tumors

Advocacy and public health sessions addressing awareness, screening, and patient engagement

Event Details

Location: Megaron Athens International Conference Centre, Athens, Greece

Who Should Attend

This congress is ideal for:

Dermatologists, oncologists, surgeons, and pathologists specializing in skin cancer

Researchers and clinicians seeking the latest scientific updates in dermato-oncology

Residents and fellows aiming to expand their expertise and network with world leaders in the field

Healthcare advocates interested in advancing melanoma awareness and policy

Why Attend

Gain cutting-edge knowledge from international experts across multiple specialties

Participate in highly interactive and practical learning sessions

Network with peers and key opinion leaders in a dynamic, global environment

Experience an inspiring educational program in one of Europe’s most historic and vibrant cities

• Topics:

CLOSING.mp4

DERMOSCOPY CONTEST I.mp4

DERMOSCOPY CONTEST II.mp4

Final_Programm_WCM2025_V5.pdf

FREE COMMUNICATION I Melanoma – systemic therapy other than ICI therapy.mp4

FREE COMMUNICATION II Squamous cell carcinoma + rare tumors.mp4

FREE COMMUNICATION III Melanoma – Epidemiology and diagnostics.mp4

FREE COMMUNICATION IV Melanoma – Experimental and translational studies.mp4

FREE COMMUNICATION V Melanoma – Surgery.mp4

FREE COMMUNICATION VI Basal cell carcinoma.mp4

FREE COMMUNICATION VII Melanoma – Immune checkpint inhibitor (ICI) therapy.mp4

KEYNOTE LECTURE KEY02 The journey from melanocytes to melanoma.mp4

KEYNOTE LECTURE KEY03 Diagnostic tools for skin cancer detection beyond dermoscopy.mp4

KEYNOTE LECTURE KEY04 New diagnostics, prognostic biomarkers and systemic therapy strategies sharply reduce the need for surgery in melanoma.mp4

KEYNOTE LECTURE KEY06 Improving outcomes in melanoma beyond the standard use of immune checkpoint blockers.mp4

Opening Ceremony.mp4

SATELLITE SYMPOSIUM SAT01 Platinum Sponsor.mp4

SATELLITE SYMPOSIUM SAT02 Gold Sponsor.mp4

SATELLITE SYMPOSIUM SAT03 Silver Sponsor.mp4

SATELLITE SYMPOSIUM SAT04 Silver Sponsor.mp4

SATELLITE SYMPOSIUM SAT05 Further Sponsor.mp4

SATELLITE SYMPOSIUM SAT06 Further Sponsor.mp4

SATELLITE SYMPOSIUM SAT07 Silver Sponsor.mp4

SATELLITE SYMPOSIUM SAT08 Gold Sponsor.mp4

SATELLITE SYMPOSIUM SAT09 Further Sponsor.mp4

SATELLITE SYMPOSIUM SAT10 Platinum Sponsor.mp4

SATELLITE SYMPOSIUM SAT11 Further Sponsor.mp4

SOCRATES’ DIALOGUES I- AN INTERACTIVE MORNING SESSION The role of microbiome for immunotherapies.mp4

SOCRATES’ DIALOGUES II- AN INTERACTIVE MORNING SESSION Treatment refractory stage IV melanomas- what do I do.mp4

SOCRATES’ DIALOGUES III- AN INTERACTIVE MORNING SESSION Women in dermato-oncology.mp4

SOCRATES’ DIALOGUES IV- AN INTERACTIVE MORNING SESSION Prognostic and predictive biomarkers for melanoma.mp4

SOCRATES’ DIALOGUES V- AN INTERACTIVE MORNING SESSION Challenges in neoadjuvant therapy.mp4

SOCRATES’ DIALOGUES VI- AN INTERACTIVE MORNING SESSION How to build up a career in dermato-oncology.mp4

SYMPOSIUM SY03 Prognostic and predictive biomarkers in melanoma.mp4

SYMPOSIUM SY08 Intralesional therapies of skin cancer.mp4

SYMPOSIUM SY09 Liquid biopsy as a decision maker in melanoma.mp4

SYMPOSIUM SY15 Neoadjuvant treatment of melanoma.mp4

SYMPOSIUM SY16 Melanoma guidelines around the world.mp4

SYMPOSIUM SY17 Immunotherapy of Merkel cell carcinoma.mp4

SYMPOSIUM SY20 Registries for real world treatment data and outcome research.mp4

SYMPOSIUM SY21 Memorial Symposium for Jeff Weber Drug resistance to immune checkpoint inhibition.mp4

SYMPOSIUM SY22 Skin Care in Organ Transplant Patients Europe (SCOPE).mp4

SYMPOSIUM SY23 Melanoma research.mp4

SYMPOSIUM SY25 Management of mucosal melanoma.mp4

SYMPOSIUM SY28 Drug resistance to targeted therapies.mp4

SYMPOSIUM SY29 Molecular tumor board for skin cancers.mp4

SYMPOSIUM SY30 Treatment of field cancerization including actinic cheilitis.mp4

SYMPOSIUM SY31 Adjuvant treatment of melanoma.mp4

SYMPOSIUM SY32 Management of brain metastasis.mp4

SYMPOSIUM SY34 Surgical pearls in the treatment of skin cancer.mp4

SYMPOSIUM SY35 Rare skin tumors (adnexal, sebaceous, DFSP).mp4

SYMPOSIUM SY36 Global epidemiologic trends and survival in skin cancer.mp4

SYMPOSIUM SY41 Mohs micrographic surgery and skin cancer management.mp4

SYMPOSIUM SY45 Primary prevention of skin cancer.mp4

SYMPOSIUM SY46 Is there a future for sentinel node biopsy.mp4

SYMPOSIUM SY47 Patient Advocacy Groups.mp4

SYMPOSIUM SY49 New devices for ..mp4

SYMPOSIUM SY53 Treatment at the end of the life.mp4

SYMPOSIUM SY54 Management of adverse events in targeted therapies.mp4

SYMPOSIUM SY55 Management of lentigo maligna and acral lentiginous melanomas.mp4

SYMPOSIUM SY56 Immune checkpoint inhibition in immunocompromised patients.mp4

SYMPOSIUM SY65 Genetic susceptibility of melanoma and cancer syndromes.mp4